UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 24, 2021
Accession Number: 0001178913-21-000747
Submission Type: POS AM
CIK: 0001498403
Company Name: BioLineRx Ltd.
File Number: 333-239485